Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11033633 ExPEC glycoconjugate vaccine formulations

Patent 11033633 was granted and assigned to Janssen Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12076385 Methods and compositions for immune protection against extra-intestinal pathogenic
0
Edits on 21 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11931405 Bioconjugates of
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+367 characters)
Article

Patent abstract

Compositions and methods for inducing an immune response against extra-intestinal pathogenic Escherichia coli (ExPEC) are described. In particular, multivalent vaccines containing O-antigen polysaccharide covalently bound to an exotoxin A of Pseudomonas aeruginosa (EPA) carrier protein that can withstand multiple environmental stresses are described.

Edits on 10 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 10 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Francesco Doro0
Janik Adriaansen0
Olga Labovitiadi0
Wouter Frank Tonnis0
Edits on 29 Jul, 2023
"Resolve patent citation"
Golden AI profile picture
Golden AI
edited on 29 Jul, 2023
Infobox
Patent Citations Received
‌
US Patent 11446370 Bioconjugates of
0
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110336330
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11446370 Bioconjugates of
0
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11529405 MDR
0
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 21 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11529405 MDR
0
Edits on 9 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11491220 Methods of producing bioconjugates of
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Current Assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110336330
Date of Patent
June 15, 2021
0
Patent Application Number
167092230
Date Filed
December 10, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110336330
Patent Citations
‌
US Patent 10159751 ExPEC glycoconjugate vaccine formulations
0
Patent Citations Received
‌
US Patent 11446370 Bioconjugates of
0
Patent Primary Examiner
‌
Brian Gangle
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 21 Sep, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11446370 Bioconjugates of
0
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11033633
Edits on 12 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Feb, 2022
Edits made to:
Infobox (+10 properties)
‌

 US Patent 11033633 ExPEC glycoconjugate vaccine formulations

Infobox
Is a
Patent
Patent
Patent applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
Current assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11033633
Date of patent
June 15, 2021
Patent application number
16709223
Date Filed
December 10, 2019
Patent citations
‌
US Patent 10159751 ExPEC glycoconjugate vaccine formulations
Patent primary examiner
‌
Brian Gangle

Find more entities like US Patent 11033633 ExPEC glycoconjugate vaccine formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo